PDF(Pubmed)
Abstract：
UNASSIGNED: Myocardial infarction (MI) in a patient with immune thrombocytopenia is a rare scenario which is very challenging to manage.
UNASSIGNED: We present a rare case of a patient with immune thrombocytopenic purpura who developed double territory segment-elevation MI with cardiogenic shock. She had an extremely rare presentation with a fresh mobile thrombus in the aortic root which was trap-dooring the right coronary artery ostium and extending into the artery with an embolism into the distal left anterior descending artery. We managed this patient conservatively with excellent recovery owing to the dangerous location of the hanging thrombus, and severe thrombocytopenia.
UNASSIGNED: Multidisciplinary approach is required for the management of MI in patients with pre-existing blood disorders, with therapy tailored to the patient\'s presentation and treatment requirements.
UNASSIGNED: We present a rare case of a patient with immune thrombocytopenic purpura who developed double territory segment-elevation MI with cardiogenic shock. She had an extremely rare presentation with a fresh mobile thrombus in the aortic root which was trap-dooring the right coronary artery ostium and extending into the artery with an embolism into the distal left anterior descending artery. We managed this patient conservatively with excellent recovery owing to the dangerous location of the hanging thrombus, and severe thrombocytopenia.
UNASSIGNED: Multidisciplinary approach is required for the management of MI in patients with pre-existing blood disorders, with therapy tailored to the patient\'s presentation and treatment requirements.
摘要：
■患有免疫性血小板减少症的患者的心肌梗死（MI）是一种罕见的情况，管理起来非常困难。
■我们介绍了一例罕见的免疫性血小板减少性紫癜患者，该患者发生双区域段抬高型心源性休克。她的表现极为罕见，主动脉根部有一个新的移动血栓，该血栓阻塞了右冠状动脉口，并延伸到动脉中，并栓塞到左前降支远端。由于悬垂血栓的危险位置，我们保守地管理了该患者，恢复良好，和严重的血小板减少症.
■需要多学科方法来管理已有血液疾病的患者的MI，根据患者的表现和治疗要求定制治疗。
■我们介绍了一例罕见的免疫性血小板减少性紫癜患者，该患者发生双区域段抬高型心源性休克。她的表现极为罕见，主动脉根部有一个新的移动血栓，该血栓阻塞了右冠状动脉口，并延伸到动脉中，并栓塞到左前降支远端。由于悬垂血栓的危险位置，我们保守地管理了该患者，恢复良好，和严重的血小板减少症.
■需要多学科方法来管理已有血液疾病的患者的MI，根据患者的表现和治疗要求定制治疗。
